摘要:
A method for manufacturing an instant egg/edible bird's nest soup with fermented glutinous rice, comprising the steps of preparing the fermented glutinous rice wine, separating the wine juice from the rice dregs, preparing the dehydrated egg droppings/edible bird's nest shreds, vacuum freeze drying and vacuum packing; the instant egg/edible bird's-nest soup with fermented glutinous rice manufactured according to the method of the present invention is easily portable, and can be immediately consumed after being brewed in hot water; the flavor of the brewed egg/edible bird's nest soup with fermented glutinous rice is fresh and sweet; the shape of the rice dregs and the egg droppings/edible bird's nest shreds can be perfectly kept, and the rice dregs and egg droppings/edible bird's nest shreds are soft and good-tasting.
摘要:
Provided herein is a culture medium for in-vitro cultivation of Mycobacterium leprae (M. Leprae) comprising: a) a solid phase comprising Lowenstein-Jensen medium, and b) a liquid phase comprising a stock solution of Middlebrook 7H9, Middlebrook Growth Supplement, thyroxine, glycerol and a mixture of an antifungal agents and antibiotics.
摘要:
The invention relates to a bread dough, which includes:one or more fructans having two or more fructosyl moieties linked by a beta(2,1) bond,one or more inulinases (EC 3.2.1.7 and EC 3.2.1.80), andone or more invertases (3.2.1.26), the bread dough having a total added sugar content of 0-5 wt. %, based on dry weight.The invention further relates to a bread obtained by baking the dough and to a sugar replacement system for bread and to a bread pre-mix.
摘要:
A composition and method for an avenanthramide-enriched, oat-based product having improved health effects. The oat-based product includes an avenanthramide ingredient having avenanthramides 2c:2p:2f in ratios comprising at least one of 1:1:1 or 1:2:2. More particularly, the avenanthramide ingredient may be derived synthetically or recovered from processing raw oats into constituent oat fractions.
摘要:
Embodiments of the disclosure are drawn to an enteral feeding device for hydrolyzing triglycerides in a nutritional formula. The device may include a body housing a chamber, an inlet configured to fluidly couple with a source of nutritional formula, and an outlet configured to fluidly couple with an enteral feeding tube. The device may include a headspace and a plurality of particles contained within the chamber, wherein the lipase is covalently bonded to the plurality of particles. The device may include an inlet filter located between the inlet and the chamber, wherein the inlet filter contains a first plurality of openings, and an outlet filter located between the chamber and the outlet, wherein the outlet filter has a second plurality of openings smaller than the plurality of particles.
摘要:
The present invention provides a method for breaking sporoderm of Ganoderma spore powder, and food and beverage products obtained by the same. The sporoderm-breaking method includes the steps of: putting 5 to 10 parts by weight of Ganoderma spore powder into 60 to 100 parts by volume of water; stirring fully to form a mixture; performing a sporoderm-breaking treatment on the mixture to obtain a sporoderm-broken spore powder solution; optionally, filtering the sporoderm-broken spore powder solution to obtain a plurality of filtrates; and pooling and drying the filtrates to obtain a dried Ganoderma spore powder extract. The sporoderm-breaking treatment comprises slowly heating the mixture to a temperature ranging between 63 and 100° C.; and maintaining at the temperature for 15 to 60 min. The sporoderm-breaking method of the present invention can significantly improve sporoderm-breaking rate of Ganoderma spore powder, preserve the active ingredients in raw materials of Ganoderma spore powder.
摘要:
The present invention discloses a drug screening method, drugs promoting extracellular matrix protein crosslinking and their applications, the said drug screening method, is used to screen out materials promoting the expression of LOXL1 gene, wherein, the said drug screening method contains the following steps: A, Construct the 2nd generation lentiviral vector used to control the ZsGreen expression by human LOXL 1 gene promoter. B, Infect human fibroblasts with the 2nd generation lentiviral vector, and construct the new human fibroblasts which integrate PLOXL1-ZsGreen components. C, Drug screening: Inoculate the said human fibroblasts integrating PLOXL1-ZsGreen components into culture medium. Add the analyte into the cell culture medium containing human fibroblast cells. After culturing, detect the green fluorescence intensity of these fibroblast cells, then decide if the analyte promotes LOXL1 gene expression by checking if the green fluorescence intensity is increased. The method provided by the present invention is easy to operate and widely applicable.
摘要:
Food additives may be actively released to deliver aromatic compounds to consumers during food or drink consumption. The food additives may be contained within an encapsulation layer. The encapsulation layer may be configured to release the food additives in response to being exposed to energy provided by an activation source proximate to the food additives. The activation source may be incorporated into, or connected with, an eating utensil or an oral implant. The activation source can be manually controlled by a consumer, can be controlled based on conditions near the food additives, or can be programmed with a release schedule that defines how and when food additives are to be released.
摘要:
A method for producing a low-prolamine product from a prolamine-bearing seed. Prolamine protein is extracted from the prolamine-bearing seed with an alcoholic solvent selected for solubilizing the prolamine to produce an extraction slurry. A solids fraction in the extraction slurry is removed from a prolamine fraction. The solids fraction is desolventized to provide the low-prolamine product.